HSS Studies Highlight Perioperative Considerations for GLP-1 Medication Users
Researchers at the Hospital for Special Surgery (HSS) presented studies at the American Society of Regional Anesthesia and Pain Medicine meeting, focusing on the use of GLP-1 agonists in surgical patients. These medications, used for type 2 diabetes and obesity, are increasingly prescribed for other conditions. The studies examined the impact of GLP-1s on gastric emptying and their prevalence among hip and knee arthroplasty patients. Findings showed a significant increase in GLP-1 use from 2021 to 2024, with implications for surgical safety and management. 
